T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial | Nature Medicine
Covid: Brian Pinker, 82, first to get Oxford-AstraZeneca vaccine - BBC News
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - The Lancet
Should I reduce the interval between my 1st and 2nd Astra Zeneca COVID 19 Vaccination doses? – Gerringong Medical Practice
Denmark suspends use of AstraZeneca Covid vaccine
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine - ScienceDirect
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK - The Lancet
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
Explainer: Impact of Covishield's 4-8 week interval on India's covid vaccination | Mint
Oxford/AstraZeneca study supports UK decision to delay second doses | Financial Times
I got AstraZeneca for my first dose. Which should I get for my second?' A COVID vaccination guide - Healthy Debate
AstraZeneca: EU regulator rules vaccine 'safe' for use – DW – 03/18/2021
Mixing Pfizer, AstraZeneca Vaccines Gives Strong Covid Protection, Study Finds - The New York Times
/cloudfront-us-east-2.images.arcpublishing.com/reuters/56FYRTACBRMMFD2RN3PTNACFOI.jpg "Spanish study finds AstraZeneca vaccine followed by Pfizer dose is safe and effective | Reuters")
Spanish study finds AstraZeneca vaccine followed by Pfizer dose is safe and effective | Reuters
Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study | The BMJ
EU backs mix-and-match vaccines – DW – 12/07/2021
RACGP - Evidence suggests AstraZeneca and Pfizer are equally effective
Explainer: The confusion of Covishield dosing | Mint
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials - The Lancet
The AstraZeneca COVID-19 Vaccine and Thrombosis: What You Should Know
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England | Nature Communications
Information for Pharmacists: Everything You Need to Know about the COVID Vaccines
Changing the UK COVID-19 vaccine dosing schedule - POST
WHO backs use of Oxford/AstraZeneca Covid vaccine for adults of all ages | World Health Organization | The Guardian
Health ministry panel approves AstraZeneca's vaccine for people 40 and over | The Japan Times
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study | The BMJ
